Followers | 69 |
Posts | 2105 |
Boards Moderated | 0 |
Alias Born | 02/06/2014 |
Tuesday, February 16, 2021 2:47:51 AM
Recent AMGN News
- Microsoft and Meta Decline Up to 4%; Roku Falls 14% Amid Lower Estimates; Booking Surges 6%; Carvana Soars 20% • IH Market News • 10/31/2024 11:13:28 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2024 08:06:04 PM
- AMGEN REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS • PR Newswire (US) • 10/30/2024 08:01:00 PM
- AMGEN ANNOUNCES 2024 FOURTH QUARTER DIVIDEND • PR Newswire (US) • 10/25/2024 08:00:00 PM
- AMGEN ANNOUNCES WEBCAST OF 2024 THIRD QUARTER FINANCIAL RESULTS • PR Newswire (US) • 10/24/2024 08:00:00 PM
- AMGEN PRESENTS POSITIVE PHASE 3 DATA FOR UPLIZNA® (INEBILIZUMAB-CDON) IN GENERALIZED MYASTHENIA GRAVIS (GMG) AT AANEM 2024 • PR Newswire (US) • 10/15/2024 12:00:00 PM
- LA LA ANTHONY PARTNERS WITH AMGEN TO SHARE CANDID, BEHIND-THE-SCENES LOOK AT HOW PLAQUE PSORIASIS AFFECTS HER LIFE • PR Newswire (US) • 10/01/2024 01:00:00 PM
- Dow, S&P Come Off Record Highs, Close On Weak Note • IH Market News • 09/25/2024 08:45:00 PM
- TEPEZZA® (TEPROTUMUMAB) RECEIVES APPROVAL IN JAPAN FOR THE TREATMENT OF ACTIVE THYROID EYE DISEASE • PR Newswire (US) • 09/24/2024 08:00:00 PM
- AMGEN TO HOST CONFERENCE CALL TO DISCUSS NEW TOPLINE DATA IN INFLAMMATION AND RARE DISEASE • PR Newswire (US) • 09/23/2024 08:00:00 PM
- AMGEN TO PRESENT DATA FROM MULTIPLE EARLY-STAGE CLINICAL TRIALS AT ESMO 2024 • PR Newswire (US) • 09/13/2024 01:00:00 PM
- AMGEN PRESENTS NEW DATA FOR FIRST-IN-CLASS IMDELLTRA™ (TARLATAMAB-DLLE) IN SMALL CELL LUNG CANCER AT WCLC 2024 • PR Newswire (US) • 09/09/2024 01:00:00 PM
- AMGEN TO PRESENT AT THE 2024 WELLS FARGO HEALTHCARE CONFERENCE • PR Newswire (US) • 08/30/2024 08:00:00 PM
- AMGEN TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE • PR Newswire (US) • 08/29/2024 08:00:00 PM
- Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 08/23/2024 08:20:27 PM
- OTEZLA® (APREMILAST) NOW AVAILABLE IN THE U.S. FOR MODERATE TO SEVERE PEDIATRIC PLAQUE PSORIASIS • PR Newswire (US) • 08/20/2024 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 09:44:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 09:43:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/13/2024 09:41:36 PM
- Novo Nordisk Adjusts Outlook, Airbnb Drops 16% on Declining U.S. Demand, Lumen Technologies Surges 48% in Premarket • IH Market News • 08/07/2024 09:42:51 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:05:06 PM
- AMGEN REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS • PR Newswire (US) • 08/06/2024 08:01:00 PM
- US Index Futures Rise After Market Sell-off, Oil Prices Trim Losses • IH Market News • 08/06/2024 09:49:06 AM
- AMGEN ANNOUNCES 2024 THIRD QUARTER DIVIDEND • PR Newswire (US) • 08/02/2024 08:00:00 PM
- AMGEN ANNOUNCES WEBCAST OF 2024 SECOND QUARTER FINANCIAL RESULTS • PR Newswire (US) • 08/01/2024 08:00:00 PM
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM